These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4085069)

  • 1. Direct determination of cis-dichlorodiammineplatinum(II) in urine by derivative spectroscopy.
    Inagaki K; Yonehara S; Kidani Y
    Chem Pharm Bull (Tokyo); 1985 Aug; 33(8):3369-74. PubMed ID: 4085069
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative changes in cis-dichlorodiammineplatinum(II) speciation in excreted urine with time after iv infusion in man: methods of analysis, preliminary studies, and clinical results.
    LeRoy AF; Wehling M; Gormley P; Egorin M; Ostrow S; Bachur N; Wiernik P
    Cancer Treat Rep; 1980 Jan; 64(1):123-32. PubMed ID: 7189692
    [No Abstract]   [Full Text] [Related]  

  • 3. A method for determining cis-dichlorodiammineplatinum(II) in plasma and urine by high performance liquid chromatography with direct ultraviolet detection.
    Kizu R; Higashi S; Miyazaki M
    Chem Pharm Bull (Tokyo); 1985 Oct; 33(10):4614-7. PubMed ID: 4092275
    [No Abstract]   [Full Text] [Related]  

  • 4. Urine analysis of platinum species derived from cis-dichlorodiammineplatinum(II) by high-performance liquid chromatography following derivatization with sodium diethyldithiocarbamate.
    Bannister SJ; Sternson LA; Repta AJ
    J Chromatogr; 1979 May; 173(2):333-42. PubMed ID: 232706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal excretion kinetics of high-dose cis-dichlorodiammineplatinum(II) administered with hydration and mannitol diuresis.
    Frick GA; Ballentine R; Driever CW; Kramer WG
    Cancer Treat Rep; 1979 Jan; 63(1):13-6. PubMed ID: 421230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model.
    Cvitkovic E; Spaulding J; Bethune V; Martin J; Whitmore WF
    Cancer; 1977 Apr; 39(4):1357-61. PubMed ID: 856436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of reductive amperometric detection in the liquid chromatographic determination of antineoplastic platinum complexes.
    Bannister SJ; Sternson LA; Repta AJ
    J Chromatogr; 1983 Apr; 273(2):301-18. PubMed ID: 6683277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II).
    DeSimone PA; Yancey RS; Coupal JJ; Butts JD; Hoeschel JD
    Cancer Treat Rep; 1979 Jun; 63(6):951-60. PubMed ID: 466654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of Cis-dichlorodiammineplatinum(II) (NSC-119875) at ehe cellular level.
    Drewinko B; Gottlieb JA
    Cancer Chemother Rep; 1975; 59(3):665-73. PubMed ID: 1203891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voltammetric determination of platinum from aqueous solutions and from urine.
    Schmid GM; Atherton DR
    Anal Chem; 1986 Aug; 58(9):1956-9. PubMed ID: 3752518
    [No Abstract]   [Full Text] [Related]  

  • 11. Modification of the renal toxicity of cis-dichlorodiammineplatinum(II) with furosemide in male F344 rats.
    Ward JM; Grabin ME; LeRoy AF; Young DM
    Cancer Treat Rep; 1977; 61(3):375-9. PubMed ID: 872137
    [No Abstract]   [Full Text] [Related]  

  • 12. Some quantitative data on cis-dichlorodiammineplatinum(II) species in solution.
    LeRoy AF
    Cancer Treat Rep; 1979 Feb; 63(2):231-3. PubMed ID: 36228
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of frusemide on cis-dichlorodiammineplatinum (II) pharmaco-kinetics.
    Dumas M; d'Athis P; de Gislain C; Lautissier JL; Autissier N; Escousse A; Guerrin J
    Eur J Drug Metab Pharmacokinet; 1987; 12(3):203-6. PubMed ID: 3436343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C.
    Barlogie B; Corry PM; Drewinko B
    Cancer Res; 1980 Apr; 40(4):1165-8. PubMed ID: 7188883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SOS chromotest study on cisplatin: the genotoxicity evaluation and analytical determination in human urine.
    Vojteková H; Svorc J; Miertus S
    Neoplasma; 1990; 37(6):667-74. PubMed ID: 2125698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fourth-derivative spectrophotometric determination of fungicide ferbam (iron(III) dimethyldithiocarbamate) in a commercial sample and wheat grains using 2,2'-bipyridyl.
    Malik AK; Bansal S; Aulakh JS
    Anal Bioanal Chem; 2003 Apr; 375(8):1250-3. PubMed ID: 12733047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies.
    Piel IJ; Perlia CP
    Cancer Chemother Rep; 1975; 59(5):995-9. PubMed ID: 1106849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polarographic activity of the antitumor drug cis-dichlorodiammineplatinum (II). The effect of hydrolysis and trans-isomerization of the drug.
    Vrána O; Kleinwächter V; Brabec V
    Experientia; 1984 May; 40(5):446-51. PubMed ID: 6539245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of cisplatin and cis-diammineaquachloroplatinum(II) ion by liquid chromatography using post-column derivatization with diethyldithiocarbamate.
    Andersson A; Ehrsson H
    J Chromatogr; 1994 Feb; 652(2):203-10. PubMed ID: 8006105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemical and biological effects of cis-dichlorodiammineplatinum (II), an antitumor agent, on DNA.
    Munchausen LL
    Proc Natl Acad Sci U S A; 1974 Nov; 71(11):4519-22. PubMed ID: 4548188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.